Related Experiment Video
Updated: Feb 1, 2026

Automated Measurement of Cryptococcal Species Polysaccharide Capsule and Cell Body
Published on: January 11, 2018
Emerging concepts in HIV-associated cryptococcal meningitis
David S Lawrence1,2, Timothée Boyer-Chammard3,4, Joseph N Jarvis1,2
1Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
Insights
HIV-associated cryptococcal meningitis is a major cause of AIDS mortality. New treatments and trials show promise in reducing deaths from this serious infection.
Area of Science:
- Infectious Diseases
- Neuroscience
- Immunology
Background:
- HIV-associated cryptococcal meningitis contributes significantly to AIDS-related mortality.
- Despite advances in antiretroviral therapy, mortality rates remain high, around 40% in clinical trials.
- Cryptococcal meningitis causes an estimated 181,100 deaths annually worldwide.
Purpose of the Study:
- To review recent findings and ongoing clinical trials for HIV-associated cryptococcal meningitis.
- To highlight advancements in optimizing induction therapy for this opportunistic infection.
- To advocate for improved access to essential antifungal medications.
Main Methods:
- Review of global burden of disease data.
- Analysis of clinical trial outcomes and emerging treatment protocols.
- Evaluation of antifungal treatment strategies, including amphotericin B, flucytosine, and fluconazole.
Main Results:
- Screening for cryptococcal antigen and preemptive antifungal treatment can reduce incidence and mortality.
- Shortening amphotericin B treatment to 7 days with flucytosine improves outcomes and reduces toxicity.
- Flucytosine is a superior adjunct to amphotericin B compared to fluconazole.
- Oral antifungal combinations of flucytosine and fluconazole offer an alternative treatment where amphotericin B is unavailable.
- A single high-dose of liposomal amphotericin B is being evaluated for efficacy.
Conclusions:
- Ongoing clinical trials are crucial for optimizing cryptococcal meningitis induction therapy.
- Increased access to amphotericin formulations and flucytosine is essential.
- Combined screening, preemptive treatment, and optimized therapy can reduce mortality from HIV-associated cryptococcal meningitis.
Purpose Of Review:
HIV-associated cryptococcal meningitis remains a significant contributor to AIDS-related mortality despite widened access to antiretroviral therapy. Even in clinical trial settings 10-week mortality is roughly 40%. A number of important clinical trials have either recently concluded or are actively recruiting.
Recent Findings:
Global burden of disease estimates suggest cryptococcal meningitis causes 181 100 deaths annually. Screening blood for cryptococcal antigen in HIV-infected individuals with CD4 cell counts less than 100 cells/microl and preemptive antifungal treatment for those with detectable cryptococcal antigen reduces the incidence of cryptococcal meningitis and is likely to reduce mortality. Cryptococcal meningitis treatment with conventional 14-day courses of amphotericin are associated with high toxicity and mortality and can be reduced to 7 days if given alongside flucytosine. Flucytosine is a significantly superior adjunct to amphotericin treatment compared with fluconazole. In settings without amphotericin B dual oral antifungal combinations of flucytosine and fluconazole offer an effective alternative treatment. A single, high-dose of liposomal amphotericin is effective at reducing fungal burden and is being tested in a phase III trial.
Summary:
Recently completed and ongoing clinical trials are increasing our understanding of how to optimize induction therapy for cryptococcal meningitis. Advocacy efforts are needed to broaden access to amphotericin formulations and flucytosine.
Related Concept Videos
Cranial and Spinal Meninges
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
Emerging Adulthood
Self-Concept
Infancy and Emerging Recognition
During infancy, self-concept is virtually nonexistent. Babies do not distinguish themselves as separate entities and often mistake their...
Concepts and Prototypes
The brain organizes this information using concepts, which are mental categories grouping linguistic data,...
Formula Mass and Mole Concepts of Compounds
Basic Concept
Length, which measures the distance traveled by an object, is a fundamental concept in engineering mechanics. We use coordinates relative to a reference point to describe the distance. Length not only helps to describe the...

